pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 14·1 min read
save

Physician warns AI could undermine authentic care in addiction treatment

May 14, 2026·read at STAT ↗Negative

Physician Steve D. Klein, an addiction medicine specialist, argues that recent AI tools marketed for addiction care miss the core of patient treatment. He describes seeing a prototype that, while technically impressive, failed to respect the nuanced relationship between doctor and patient.

Klein warns that patients in recovery could mistake algorithmic responses for genuine empathy, creating an unhealthy emotional attachment. He stresses that authentic, bidirectional connection is a therapeutic cornerstone that AI cannot replicate.

The loss of this connection, he says, could harm both subjective experiences and objective health outcomes for people battling addiction. He cautions that unchecked AI use may undermine treatment effectiveness.

While critical of the current approach, Klein acknowledges that AI can aid clinicians by organizing information and improving efficiency. He advocates for careful integration that preserves the art of medicine rather than replacing it.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Using AI in addiction medicine could be particularly risky”

read at STAT ↗
1,305 words · retrieved May 14
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
HematologyPsychiatry & CNSType 2 Diabetes

related stories

  • Sep 23STAT+: UnitedHealth, CVS push back on Medicare plan to curb remote patient monitoringSTAT
  • Sep 21Behind the outcomes: How whole-patient support is reshaping oncology careBioPharma Dive
  • Sep 17Purer fentanyl won’t solve the U.S. overdose death crisis, study saysSTAT
  • Sep 15STAT+: Medicare to expand its pilot that pays for technology to manage chronic diseasesSTAT
  • Sep 4Opinion: The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear remainsSTAT